Yat Sun Or - 01 Dec 2025 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Chief Scientific Officer
Signature
/s/ Matthew Kowalsky as attorney-in-fact
Issuer symbol
ENTA
Transactions as of
01 Dec 2025
Transactions value $
-$10,632
Form type
4
Date filed
03 Dec 2025, 16:36
Previous filing
26 Nov 2025
Next filing
05 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Or Yat Sun Chief Scientific Officer C/O ENANTA PHARMACEUTICALS, INC., 4 KINGSBURY AVENUE, WATERTOWN /s/ Matthew Kowalsky as attorney-in-fact 2025-12-03 0001571212

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Tax liability -$10.6K -753 -0.2% $14.12 374K 01 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021.